High-Quality Mots-C Peptide 16 Amino Acids - China Suppliers and Factory for Metabolic Regulation and Insulin Sensitivity Quotes, Pricelist
Product Description
Mots-c is a short peptide composed of 16 amino acids, and its encoding gene is located on mitochondrial DNA. This discovery challenges the conventional wisdom that mitochondrial DNA only encodes respiratory chain-related proteins.
The core function of Mots-c is as a regulator of cellular metabolism, particularly in glucose metabolism and insulin sensitivity. It mimics some of the effects of exercise and is therefore also known as a "motor-mimicking peptide".
It primarily functions by activating the AMPK pathway, a key energy sensor within cells. This promotes glucose uptake by cells, improves insulin sensitivity, and influences fatty acid metabolism.
Therapeutic Areas
Based on its powerful metabolic regulation capabilities, research on Mots-c mainly focuses on the following therapeutic areas:
Metabolic diseases
- Type 2 diabetes: This is Mots-c's core research focus. It can significantly improve insulin resistance and lower blood sugar, and has the potential to become a novel antidiabetic drug.
- Obesity: Mots-c can promote energy expenditure, reduce fat accumulation, and induce the conversion of white fat into brown fat-like fat (thermogenesis), thereby helping to control weight.
Aging and related diseases
- Anti-aging/Extending healthy lifespan: Mots-c can improve age-related metabolic decline, enhance the cells' resistance to stress, and has shown the potential to extend healthy lifespan in animal experiments.
- Sarcopenia: By improving metabolism and promoting muscle health, it may help combat muscle loss caused by age or disease.
- Neurodegenerative diseases: Preliminary studies suggest it may have a protective effect against diseases such as Alzheimer's, mainly by improving brain cell energy metabolism and reducing oxidative stress.
Athletic performance and recovery
As a "sports simulator," it has been explored for its use in enhancing physical fitness, improving exercise endurance, and accelerating post-exercise recovery.
Other potential areas
Cardiovascular protection, non-alcoholic fatty liver disease, and other diseases closely related to metabolic disorders.
Outlook & Development
Mots-c has a promising future, but it is still in the critical stage of translating from basic research to clinical application.
Opportunities and Prospects
- A novel target of action: As the first mitochondrial-derived peptide to be extensively studied, it opens up a completely new path for drug development and has huge market potential.
- Targeting the underlying mechanism: It targets the common core of aging and metabolic diseases—the imbalance of cellular energy metabolism—and therefore may have multiple benefits.
- The concept of "sports pills": Suggests a treatment option that mimics the benefits of exercise for people who are unable to exercise enough (such as the elderly and those with mobility impairments), and there is a clear market demand for this.
Challenges and Current Situation
- Research and development phase: Currently, the vast majority of data comes from preclinical studies (cell and animal experiments). Advancing to human clinical trials is the biggest challenge and the most critical step.
- Administration route: As a peptide, it is easily degraded, and issues such as administration route (e.g., low oral bioavailability, usually requiring injection) and stability need to be addressed.
- Long-term safety and dosage: The long-term effects, optimal dosage and potential side effects in humans require further investigation.
- Industrialization and regulation: How to synthesize or produce this peptide on a large scale and with high quality, and obtain approval from drug regulatory agencies (such as the FDA and NMPA), is the only way to achieve industrialization.
Conclusion
In summary, Mots-c is a revolutionary biological discovery representing a crucial future direction in the fields of metabolic diseases and anti-aging. Its scientific value has been proven, but its true success will depend on the progress and results of clinical translational research in the coming years. It holds the promise of moving from the laboratory to the market as a groundbreaking new therapeutic agent.
